期刊文献+

氢吗啡酮联合芬太尼在妇科术后自控镇痛中临床应用 被引量:2

原文传递
导出
摘要 目的探讨氢吗啡酮联合芬太尼用于骨科患者术后自控静脉镇痛的临床效果。方法 50例行妇科手术患者,随机分为观察组和对照组各25例,2组术后均采用患者静脉自控镇痛的方式,对照组给予芬太尼1.0 mg,观察组给予氢吗啡酮1.6 mg+芬太尼0.5 mg,记录术后2、4、8、12、24 h的疼痛评分(VAS评分)、Ramsay镇静评分(RSS评分)和按压次数,观察恶心、呕吐、眩晕等不良反应的发生情况。结果观察组患者术后2、4、8、12、24时VAS评分和按压次数均明显低于对照组、RSS评分均高于对照组(P<0.05);观察组镇痛治疗期间恶心呕吐、眩晕不良反应发生率明显低于对照组(P<0.05)。结论氢吗啡酮联合芬太尼用于妇科术后镇痛效果好于单用芬太尼,且不良反应发生率低。
作者 陈豪
出处 《医药论坛杂志》 2015年第10期158-159,共2页 Journal of Medical Forum
  • 相关文献

参考文献4

  • 1Chang AK,Bijur PE,Davitt M,et al.Randomized Clinical Trial of an Intravenous Hydromorphone Titration Protocol versus U-sual Care for Management of Acute Pain in Older Emergency Department Patients[J].Drugs Aging,2013,30(9):747-754.
  • 2Kumar P,Sunkaraneni S,Sirohi S,et al.Hydromorphone effie-aey and treatment protoeol impaet on toleranee and mu-opioid reeeptor relation[J].Eur J Pharmaeol,2008,597(1-3):39-45.
  • 3刘汝,胡啸玲,易汉,冯娟,文建.盐酸氢吗啡酮的临床研究进展[J].中国处方药,2014,12(3):119-121. 被引量:57
  • 4Liukas A,Kuusniemi K,Aantaa R,et al.Plasma concentrations of oral oxycodone are greatly increased in the elderly[J].Clin Pharmacol Ther,2008,84(4):462-467.

二级参考文献18

  • 1Kumar P, Sunkaraneni S, Sirohi S, et al. Hydromorphone efficacyand treatment protocol impact on tolerance and mu-opioid receptorregulation. Eur J Pharmacol, 2008, 597(1-3):39-45.
  • 2Felden L, Walter C, Harder S, et al. Comparative clinical effectsof hydromorphone and morphine: a meta-analysis. Br J Anaesth, 2011, 107(3):319-328.
  • 3Lussier D, Richarz U, Finco G. Use of hydromorphone, withparticular reference to the OROS formulation, in the elderly. Drugs aging,2010, 27(4):327-335.
  • 4Davison SN, Mayo PR. Pain management in chronic kidneydisease: the pharmacokinetics and pharmacodynamics of hydromorphoneand hydromorphone-3-glucuronide in hemodialysis patients. J OpioidManag, 2008, 4(6):335-336, 339-344.
  • 5Rauch E. Intrathecal hydromorphone for postoperative analgesiaafter cesarean delivery: a retrospective study. AANA J, 2012, 80(4Suppl):S25-32.
  • 6Johansen MJ, Satterfield WC, Baze WB, et al. Continuousintrathecal infusion of hydromorphone: safety in sheep model and clinicalimplications. Pain Med, 2004, 5(1):14-25.
  • 7Rauch E. Intrathecal hydromorphone for cesarean delivery: insearch of improved postoperative pain management: a case report. AANA J.2011, 79(5):427-432.
  • 8Lee YS, Park YC, Kim JH, et al. Intrathecal hydromorphoneadded to hyperbaric bupivacaine for postoperative pain relief after kneearthroscopic surgery: a prospective, randomised, controlled trial. Eur JAnaesthesiol, 2012, 29(1):17-21.
  • 9Chang AK, Bijur PE, Lupow JB, et al. Randomized clinical trial ofthe 2 mg hydromorphone bolus protocol versus the "1 + 1" hydromorphonetitration protocol in treatment of acute, severe pain in the first hour ofemergency department presentation. Ann Emerg Med, 2013, 62(4):304-310.
  • 10Oldenmenger WH, Lieverse PJ, Janssen PJ, etal. Efficacy ofopioid rotation to continuous parenteral hydromorphone in advanced cancerpatients failing on other opioids. Support Care Cancer, 2012, 20(8):1639-1647.

共引文献56

同被引文献23

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部